159 related articles for article (PubMed ID: 23434220)
21. High-dose-rate intraoperative brachytherapy (IOHDR) using flab technique in the treatment of soft tissue sarcomas.
Rachbauer F; Sztankay A; Kreczy A; Sununu T; Bach C; Nogler M; Krismer M; Eichberger P; Schiestl B; Lukas P
Strahlenther Onkol; 2003 Jul; 179(7):480-5. PubMed ID: 12835885
[TBL] [Abstract][Full Text] [Related]
22. The impact of brachytherapy on prostate cancer-specific mortality for definitive radiation therapy of high-grade prostate cancer: a population-based analysis.
Shen X; Keith SW; Mishra MV; Dicker AP; Showalter TN
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1154-9. PubMed ID: 22270175
[TBL] [Abstract][Full Text] [Related]
23. Interstitial brachytherapy in soft tissue sarcomas: the Rambam experience.
Rosenblatt E; Meushar N; Bar-Deroma R; Drumea K; Stein M; Zidan J; Kuten A
Isr Med Assoc J; 2003 Aug; 5(8):547-51. PubMed ID: 12929290
[TBL] [Abstract][Full Text] [Related]
24. Intraoperative high-dose-rate brachytherapy: An American Brachytherapy Society consensus report.
Lloyd S; Alektiar KM; Nag S; Huang YJ; Deufel CL; Mourtada F; Gaffney DK
Brachytherapy; 2017; 16(3):446-465. PubMed ID: 28173994
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant high dose rate brachytherapy in the management of soft tissue sarcoma: a dose-toxicity analysis.
Aronowitz JN; Pohar SS; Liu L; Haq R; Damron TA
Am J Clin Oncol; 2006 Oct; 29(5):508-13. PubMed ID: 17023788
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
[TBL] [Abstract][Full Text] [Related]
27. Nerve tolerance to high-dose-rate brachytherapy in patients with soft tissue sarcoma: a retrospective study.
Kubo T; Sugita T; Shimose S; Matsuo T; Hirao K; Kimura H; Kenjo M; Ochi M
BMC Cancer; 2005 Jul; 5():79. PubMed ID: 16026629
[TBL] [Abstract][Full Text] [Related]
28. High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: a 7-year experience.
Aluwini S; van Rooij PH; Kirkels WJ; Jansen PP; Praag JO; Bangma CH; Kolkman-Deurloo IK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1480-5. PubMed ID: 22285661
[TBL] [Abstract][Full Text] [Related]
29. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy.
San Miguel I; San Julián M; Cambeiro M; Fernández Sanmamed M; Vázquez-García B; Pagola M; Gaztañaga M; Martín-Algarra S; Martinez-Monge R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e529-39. PubMed ID: 21665380
[TBL] [Abstract][Full Text] [Related]
30. Local control and survival in patients with soft tissue sarcomas treated with limb sparing surgery in combination with interstitial brachytherapy and external radiation.
Muhic A; Hovgaard D; Mørk Petersen M; Daugaard S; Højlund Bech B; Roed H; Kjaer-Kristoffersen F; Aage Engelholm S
Radiother Oncol; 2008 Sep; 88(3):382-7. PubMed ID: 18584905
[TBL] [Abstract][Full Text] [Related]
31. Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas.
Martínez-Monge R; Garrán C; Cambeiro M; San Julián M; Alcalde J; Sierrasesúmaga L
Brachytherapy; 2004; 3(4):196-200. PubMed ID: 15607151
[TBL] [Abstract][Full Text] [Related]
32. Interstitial brachytherapy for childhood soft tissue sarcoma.
Laskar S; Bahl G; Ann Muckaden M; Puri A; Agarwal MG; Patil N; Shrivastava SK; Dinshaw KA
Pediatr Blood Cancer; 2007 Oct; 49(5):649-55. PubMed ID: 17226842
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
34. Perioperative interstitial brachytherapy for soft tissue sarcomas: prognostic factors and long-term results of 155 patients.
Laskar S; Bahl G; Puri A; Agarwal MG; Muckaden M; Patil N; Jambhekar N; Gupta S; Deshpande DD; Shrivastava SK; Dinshaw KA
Ann Surg Oncol; 2007 Feb; 14(2):560-7. PubMed ID: 17115103
[TBL] [Abstract][Full Text] [Related]
35. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
36. Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk.
Lazzaro G; Lazzari R; Pelosi G; De Pas T; Mariani L; Mazzarol G; Sances D; Tosti G; Baldini F; Mosconi M; Tedeschi I; Viale G; Marsiglia H; Chiappa A; Vavassori A; Orecchia R; Testori A
Ann Surg Oncol; 2005 Nov; 12(11):935-42. PubMed ID: 16195832
[TBL] [Abstract][Full Text] [Related]
37. Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications.
Nijdam W; Levendag P; Noever I; Groot CU; Agthoven Mv
Radiother Oncol; 2005 Oct; 77(1):65-72. PubMed ID: 16213619
[TBL] [Abstract][Full Text] [Related]
38. 192Ir low dose rate brachytherapy for boosting locally advanced prostate cancers after external beam radiotherapy: a phase II trial.
Nickers P; Coppens L; de Leval J; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jun; 79(3):329-34. PubMed ID: 16780976
[TBL] [Abstract][Full Text] [Related]
39. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
Vicini FA; Kestin LL; Martinez AA
Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
[TBL] [Abstract][Full Text] [Related]
40. [Brachytherapy for extremity soft tissue sarcomas].
Delannes M; Thomas L; Brun T; David I; Ducassou A
Cancer Radiother; 2013 Apr; 17(2):151-4. PubMed ID: 23402876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
